{
  "topics": {
    "covid19": 8156,
    "sarscov2": 1481,
    "coronavirus": 1309,
    "pneumonia": 1110,
    "pandemic": 942,
    "placebocontrolled": 700,
    "covid": 693,
    "doubleblind": 655,
    "multicenter": 636,
    "hospitalized": 537,
    "openlabel": 374,
    "immunogenicity": 322,
    "hydroxychloroquine": 278,
    "vaccination": 231,
    "distress": 225,
    "retrospective": 221,
    "convalescent": 207,
    "tolerability": 207,
    "pulmonary": 194,
    "feasibility": 166,
    "multicentre": 162,
    "ards": 145,
    "inflammatory": 134,
    "prophylaxis": 132,
    "ventilation": 127,
    "tertiary": 126,
    "intravenous": 114,
    "prevalence": 114,
    "corona": 113,
    "nasal": 111,
    "mesenchymal": 108,
    "asymptomatic": 106,
    "longterm": 106,
    "icu": 105,
    "pharmacokinetics": 104,
    "sars": 104,
    "recombinant": 103,
    "outbreak": 101,
    "symptomatic": 99,
    "epidemic": 98,
    "ivermectin": 97,
    "prognosis": 96,
    "immunity": 95,
    "tocilizumab": 93,
    "diagnosed": 89,
    "hospitalization": 86,
    "followup": 85,
    "inactivated": 84,
    "antiviral": 84,
    "cov2": 84,
    "interventional": 83,
    "vaccines": 83,
    "crosssectional": 83,
    "prophylactic": 83,
    "longitudinal": 82,
    "progression": 78,
    "hospitalised": 77,
    "wellbeing": 76,
    "cytokine": 76,
    "outpatient": 75,
    "lockdown": 70,
    "biomarkers": 70,
    "adjuvant": 70,
    "multicentric": 66,
    "inhaled": 66,
    "supplementation": 66,
    "favipiravir": 66,
    "azithromycin": 66,
    "pragmatic": 65,
    "singlecenter": 65,
    "parallelgroup": 64,
    "epidemiological": 64,
    "exploratory": 63,
    "blinded": 63,
    "ultrasound": 63,
    "prone": 62,
    "remdesivir": 61,
    "doubleblinded": 61,
    "chloroquine": 60,
    "outpatients": 59,
    "seroprevalence": 58,
    "doses": 57,
    "prognostic": 54,
    "regimen": 54,
    "dexamethasone": 53,
    "reactogenicity": 53,
    "inhalation": 53,
    "adolescents": 51,
    "antisarscov2": 50,
    "ayurvedic": 48,
    "inhibitor": 48,
    "manifestations": 48,
    "invasive": 47,
    "2019ncov": 47,
    "colchicine": 47,
    "immunological": 47,
    "highrisk": 47,
    "intubation": 46,
    "morbidity": 46,
    "predictors": 45
  },
  "sponsorsCollaborators": {
    "": 1403,
    "Assistance Publique – Hôpitaux de Paris": 139,
    "Tehran University of Medical Sciences": 115,
    "All India Institute of Medical Sciences": 100,
    "Shahid Beheshti University of Medical Sciences": 88
  },
  "publications": {
    "ClinicalTrials.gov": 6578,
    "CTRI": 1322,
    "CHICTR": 932,
    "IRCT": 619,
    "EU-CTR": 519
  },
  "countries": {
    "United States": 7029,
    "United Kingdom": 2224,
    "France": 2166,
    "China": 1628,
    "": 1403
  }
}